Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Current Leases: 2010-2025

Historic Current Leases for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to $3.2 million.

  • Ironwood Pharmaceuticals' Current Leases rose 1.99% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 1.99%. This contributed to the annual value of $3.2 million for FY2024, which is 2.02% up from last year.
  • Ironwood Pharmaceuticals' Current Leases amounted to $3.2 million in Q3 2025, which was up 0.50% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Current Leases registered a high of $3.2 million during Q3 2025, and its lowest value of $3.0 million during Q3 2022.
  • For the 3-year period, Ironwood Pharmaceuticals' Current Leases averaged around $3.2 million, with its median value being $3.2 million (2024).
  • In the last 5 years, Ironwood Pharmaceuticals' Current Leases surged by 67.59% in 2021 and then decreased by 3.39% in 2022.
  • Ironwood Pharmaceuticals' Current Leases (Quarterly) stood at $3.1 million in 2021, then dropped by 1.98% to $3.1 million in 2022, then climbed by 1.99% to $3.1 million in 2023, then rose by 2.02% to $3.2 million in 2024, then climbed by 1.99% to $3.2 million in 2025.
  • Its Current Leases was $3.2 million in Q3 2025, compared to $3.2 million in Q2 2025 and $3.2 million in Q1 2025.